Michael Paal

Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC–MS/MS method in human serum

Katharina Habler, Mathias Brügel, Daniel Teupser et al. · Journal of Pharmaceutical and Biomedical Analysis · 2021 · 94 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12

Blood purification with a cytokine adsorber for the elimination of myoglobin in critically ill patients with severe rhabdomyolysis

Christina Scharf, Uwe Liebchen, Michael Paal et al. · Critical Care · 2021 · 85 citations · Full text

Medicine, Immunology, Nephrology +12

Simultaneous quantification of cefepime, meropenem, ciprofloxacin, moxifloxacin, linezolid and piperacillin in human serum using an isotope-dilution HPLC–MS/MS method

Michael Paal, Michael Zöller, Carina Schuster et al. · Journal of Pharmaceutical and Biomedical Analysis · 2018 · 77 citations

Pharmacy, Pharmaceutical Analysis, Pharmacokinetics +15

Therapeutic Drug Monitoring of Meropenem and Piperacillin in Critical Illness—Experience and Recommendations from One Year in Routine Clinical Practice

Christina Scharf, Michael Paal, Ines Schroeder et al. · Antibiotics · 2020 · 64 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

The higher the better? Defining the optimal beta-lactam target for critically ill patients to reach infection resolution and improve outcome

Christina Scharf, Uwe Liebchen, Michael Paal et al. · Journal of Intensive Care · 2020 · 64 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17